Human chorionic gonadotropin inhibits N-methyl-N-nitrosourea-induced mammary carcinoma growth in female Lewis rats

In Vivo

Volumn 26, Issue 3, 2012, Pages 361-367

  Yuri, Takashi ^a   Lai, Yen Chang ^a   Yoshizawa, Katsuhiko ^a   Tsubura, Airo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; Chorionic gonadotropin; Estrogen; Female Lewis rats; N methyl N nitrosourea; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; ESTROGEN; ESTROGEN RECEPTOR; LUTEINIZING HORMONE RECEPTOR; METHYLNITROSOUREA; PROGESTERONE; PROGESTERONE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ESTROGEN BLOOD LEVEL; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARY; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TUMOR VOLUME; UTERUS WEIGHT;

EID: 84860845798     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bray F, McCarron P and Parkin DM: The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6: 229-239, 2004. (Pubitemid 39440251)
2. MacMahon B, Cole P and Brown J: Etiology of human breast cancer: a review. J Natl Cancer Inst 50: 21-42, 1973.
3. Chie WC, Hsieh C, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Titus-Ernstoff L, Trentham-Dietz A and MacMahon B: Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151: 715-722, 2000. (Pubitemid 30463593)
4. Yang J, Yoshizawa K, Nandi S and Tsubura A: Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. Carcinogenesis 20: 623-628, 1999. (Pubitemid 29151298)
5. Tsubura A, Uehara N, Matsuoka Y, Yoshizawa K and Yuri T: Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer. In Vivo 22: 191-201, 2008.
6. Lukanova A, Andersson R, Wulff M, Zeleniuch-Jacquotte A, Grankvist K, Dossus L, Afanasyeva Y, Johansson R, Arslan AA, Lenner P, Wadell G, Hallmans G, Toniolo P and Lundin E: Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study. Am J Epidemiol 168: 1284-1291, 2008.
7. Toniolo P, Grankvist K, Wulff M, Chen T, Johansson R, Schock H, Lenner P, Hallmans G, Lehtinen M, Kaaks R, Wadell G, Zeleniuch-Jacquotte A, Lundin E and Lukanova A: Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer. Cancer Res 70: 6779-6786, 2010.
8. Bernstein L, Hanisch R, Sullivan-Halley J and Ross RK: Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 4: 437-440, 1995.
9. Gudipudi DK, Hartzfeld K, Montemarano N and Del Priore G: Decreased breast cancer rates among women with choriocarcinoma. Gynecol Oncol 110: 202-205, 2008.
10. Russo J and Russo IH: The new paradigm in breast cancer prevention. In: Molecular Basis of Breast Cancer. Russo J and Russo IH (eds.). Berlin, Springer-Verlag, pp. 379-438, 2004.
11. Russo IH, Koszalka M and Russo J: Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis 11: 1849-1855, 1990. (Pubitemid 20331455)
12. Srivastava P, Russo J and Russo IH: Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Carcinogenesis 18: 1799-1808, 1997. (Pubitemid 28134688)
13. Meduri G, Charnaux N, Loosfelt H, Jolivet A, Spyratos F, Brailly S and Milgrom E: Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res 57: 857-864, 1997. (Pubitemid 27098009)
14. Shi SQ, Xu L, Zhao G, Yang Y and Peng JP: Apoptosis and tumor inhibition induced by human chorionic gonadotropin beta in mouse breast carcinoma. J Mol Med 84: 933-941, 2006. (Pubitemid 44655871)
15. Lopez D, Sekharam M, Coppola D and Carter WB: Purified human chorionic gonadotropin induces apoptosis in breast cancer. Mol Cancer 7: 2837-2844, 2008.
16. Rao CV, Li X, Manna SK, Lei ZM and Aggarwal BB: Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-κB and AP-1 activation. J Biol Chem 24: 25503-25510, 2004. (Pubitemid 38756809)
17. Srivastava P, Russo J and Russo IH: Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin associated with increased expression of inhibin. Mol Carcinog 26: 10-19, 1999. (Pubitemid 29420181)
18. Lojun S, Bao S, Lei ZM and Rao CV: Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer. Biol Reprod 57: 1202-1210, 1997. (Pubitemid 27461214)
19. Hudelist G, Wuelfing P, Czerwenka K, Knöfler M, Haider S, Fink-Retter A, Gschwantler-Kaulich D, Pfeiler G, Kubista E and Singer CF: Beta-hCG/LH receptor (β-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: implications for breast carcinogenesis? J Cancer Res Clin Oncol 135: 191-195, 2009.
20. Kuijper TM, Ruigrok-Ritstier K, Verhoef-Post M, Piersma D, Bruysters MW, Berns EM and Themmen AP: LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment. Mol Cell Endocrinol 302: 58-64, 2009.
21. Matzuk MM, DeMayo FJ, Hadsell LA and Kumar TR: Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice. Biol Reprod 69: 338-346, 2003. (Pubitemid 36806840)
22. Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M and Huhtaniemi I: Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 143: 4084-4095, 2002. (Pubitemid 35244387)
23. Lai YC, Yuri T, Uehara N, Matsuoka Y, Kanematsu S and Tsubura A: Biphasic effect of short-term pregnancy hormone treatment on N-methyl-N-nitrosourea- induced mammary carcinogenesis in young and old rats. Mol Med Report 2: 213-220, 2009.
24. Lai YC, Yoshizawa K, Kimura-Kawanaka A, Miki H, Sasaki T and Tsubura A: Effects of short-term pregnancy hormone treatment against N-methyl-N- nitrosourea-induced mammary carcinomas in female Lewis rats. In Vivo 25: 149-156, 2011.
25. Yuri T, Lai YC, Kanematsu S, Kuwata M, Yoshizawa K and Tsubura A: Effects of short-term estrogen treatment on the progression of N-methyl-N-nitrosourea- induced premalignant mammary lesions in female Lewis rats. Med Mol Morphol 44: 125-130, 2011.
26. Yuri T, Tsukamoto R, Uehara N, Mastuoka Y and Tsubura A: Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. In Vivo 20: 829-836, 2006. (Pubitemid 46061586)